Latest Lead News

Resolution Minerals Ltd has entered a binding agreement to acquire the Horse Heaven Project in Idaho, a promising antimony-gold-silver-tungsten asset adjacent to a major US mine, with drilling planned for 2025.

North Stawell Minerals has launched a $3.6 million equity raising, anchored by a cornerstone investor, to fund exploration at key Victorian gold projects and sustain operational momentum through 2025.

PYC Therapeutics has secured Safety Review Committee approval to increase dosing in its clinical trial for a novel treatment targeting Autosomal Dominant Optic Atrophy, a rare blinding genetic disease. This milestone marks a significant step forward in the development of PYC-001, a first-in-class RNA therapy.

Austin Engineering has raised its FY25 revenue guidance to $370 million, driven by strong growth in the Americas, but has lowered its EBIT forecast due to operational challenges in Chile.

Freehill Mining has expanded its footprint in Chile’s La Serena region by securing a third site to increase aggregate production capacity, supporting major infrastructure projects and funding future magnetite mining operations.

Helia Group announces the departure of CEO Pauline Blight-Johnston after five years, appointing CFO Michael Cant as interim CEO amid evolving market conditions. The leadership change signals a strategic pivot for the lender mortgage insurer.

IperionX has secured its first U.S. Army task order worth $1.3 million under a $99 million SBIR Phase III contract, marking a significant step in reshoring titanium production for U.S. defense needs.

Patriot Battery Metals has confirmed pollucite as the primary caesium host mineral at its Shaakichiuwaanaan Property, revealing significant caesium mineralization at the Vega and Rigel zones. The company plans to include caesium in its next Mineral Resource update and is exploring its potential as a valuable by-product alongside lithium, tantalum, and gallium.

Articore Group reaffirms its FY25 financial guidance while initiating a strategic review to unlock shareholder value, coinciding with the appointment of Vivek Kumar as Group CEO.

Radiopharm Theranostics has secured FDA Fast Track designation for RAD101, a novel imaging agent aimed at improving diagnosis of recurrent brain metastases. The move could speed development and regulatory review as the company advances its Phase 2 clinical trial.

West Coast Silver’s first two drill holes at Elizabeth Hill reveal exceptionally high-grade silver mineralisation starting from surface, confirming the project's near-term potential and setting the stage for expanded exploration.

Cyclopharm Limited has secured the maximum five-year U.S. patent extension for its flagship Technegas® Kit, extending market exclusivity to 2031 and reinforcing its strategic foothold in pulmonary imaging.